Wednesday, July 8, 2026

biotech · Relapsed/Refractory Multiple Myeloma · Relapsed/Refractory Autoimmune Diseases

Nanjing Legend Biotech

Legend Biotech is a biotech organization headquartered in Somerset, USA. Primary therapeutic focus areas include Relapsed/Refractory Multiple Myeloma, Relapsed/Refractory Autoimmune Diseases, Multiple Myeloma, Gastric Ca

2101 Cottontail Lane, Somerset, New Jersey 08873, US HQ
2,457 Employees
NMPA registrant Type
Company details
Clinical program

LB1901

Phase 1 · mab · T-Cell Lymphoma

LB1901 for T-Cell Lymphoma is a Phase 1 program (mab) at Nanjing Legend Biotech Co. with 1 ClinicalTrials.gov record(s).

Internal code LB1901-TCL-1001

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Nanjing Legend Biotech Co.
Phase
Phase 1
Modality
mab
Indication
T-Cell Lymphoma
Status
active
Trials
1

Clinical trials